Recent Quotes (30 days)

You have no recent quotes
chg | %

Genetic Technologies Limited  

(Public, ASX:GTG)   Watch this stock  
Find more results for ASX: GTG
-0.0010 (-11.11%)
Dec 15 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 0.01 - 0.01
52 week 0.01 - 0.01
Open 0.01
Vol / Avg. 113,725.00/705,535.00
Mkt cap 19.48M
P/E     -
Div/yield     -
EPS 0.00
Shares 2.44B
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin -2899.82% -1620.77%
Operating margin -2899.82% -1620.76%
EBITD margin - -1421.50%
Return on average assets -60.45% -66.18%
Return on average equity -68.33% -74.83%
Employees 64 -
CDP Score - -


60-66 Hanover St
Fitzroy, VIC 3065
+61-3-94151135 (Phone)
+61-3-84127040 (Fax)

Website links


Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The Company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/gynecologists (OBGYNs) and breast cancer risk assessment specialists, such as breast surgeons. The Company operates in Australia, the United States and Switzerland. The Company's subsidiaries include Genetic Technologies Corporation Pty. Ltd. and Phenogen Sciences Inc. Genetic Technologies Corporation Pty. Ltd. is engaged in genetic testing. The Company has launched the BREVAGen test across the United States through Phenogen Sciences Inc.

Officers and directors

Eutillio Buccilli Chief Executive Officer, Executive Director
Kevin Fischer Chief Financial Officer, Company Secretary
Mark Ostrowski President of Phenogen Sciences Inc
Age: 50
Richard Allman Ph.D Scientific Director
Age: 53
M. Luisa Ashdown Director of Global Licensing and Intellectual Property
Age: 57
Susan J. Gross M.D. Senior Medical Director
Diana Newport Quality and Business Operations Director
Age: 56
Malcolm Roy Brandon Ph.D. Non-Executive Chairman of the Board
Age: 66
Grahame James Leonard Director
Paul Alexander Kasian Non-Executive Director